Bioventix (LON:BVXP) Stock Price Passes Above 50-Day Moving Average – Here’s Why

Bioventix PLC (LON:BVXP)’s share price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 2,713.11 ($36.81) and traded as high as GBX 2,800 ($37.99). Bioventix shares last traded at GBX 2,655 ($36.02), with a volume of 1,838 shares trading hands.

Bioventix Stock Performance

The company has a market cap of £139.02 million, a price-to-earnings ratio of 17.17 and a beta of 0.35. The firm’s 50 day simple moving average is GBX 2,713.11 and its 200-day simple moving average is GBX 2,945.64.

Bioventix (LON:BVXP) last released its earnings results on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.98) EPS for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. As a group, sell-side analysts expect that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.

Bioventix Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, April 25th. Shareholders of record on Thursday, April 10th were given a dividend of GBX 70 ($0.95) per share. This represents a yield of 2.95%. The ex-dividend date was Thursday, April 10th. Bioventix’s dividend payout ratio is 102.19%.

Insider Activity at Bioventix

In other news, insider Bruce Hiscock acquired 31 shares of the company’s stock in a transaction on Monday, April 28th. The stock was purchased at an average cost of GBX 2,632 ($35.71) per share, with a total value of £815.92 ($1,107.08). 8.02% of the stock is owned by corporate insiders.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.